Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.76 and traded as high as $0.87. Nemus Bioscience shares last traded at $0.8136, with a volume of 197,253 shares changing hands.
Nemus Bioscience Price Performance
The firm has a market cap of $104.14 million, a P/E ratio of -8.64 and a beta of -0.04. The company’s 50 day moving average is $0.76.
Nemus Bioscience Company Profile
Nemus Bioscience, Inc is an early?stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Recommended Stories
- Five stocks we like better than Nemus Bioscience
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
